Endocrinological and clinical aspects of LHRH action (ICI 118630) in hormone dependent breast cancer
- 30 November 1985
- journal article
- Published by Elsevier in Journal of Steroid Biochemistry
- Vol. 23 (5) , 843-847
- https://doi.org/10.1016/s0022-4731(85)80025-x
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Slow release formulation of ‘Zoladex’ (ICI 118630) for the treatment of hormone responsive prostate and mammary tumoursJournal of Steroid Biochemistry, 1984
- TREATMENT WITH A LUTEINISING-HORMONE-RELEASING-HORMONE ANALOGUE (BUSERELIN) IN PREMENOPAUSAL PATIENTS WITH METASTATIC BREAST CANCERThe Lancet, 1982
- Use of analogues of luteinizing hormone-releasing hormone for the treatment of cancerReproduction, 1982
- REDUCED GONADOTROPIN SECRETION IN POSTMENOPAUSAL WOMEN DURING TREATMENT WITH A STIMULATORY LRH ANALOGUEJournal of Clinical Endocrinology & Metabolism, 1979
- Hypophysial Responses to Continuous and Intermittent Delivery of Hypothalamic Gonadotropin-Releasing HormoneScience, 1978
- Inhibition of Ovarian Luteinizing Hormone (LH) and Follicle-Stimulating Hormone Receptor Levels With an LH-Releasing Hormone Agonist During the Estrous Cycle in the RatFertility and Sterility, 1978
- Pituitary Gonadotropin Inhibition by a Highly Active Analog of Luteinizing Hormone-Releasing HormoneFertility and Sterility, 1978
- The Hormonal Activity of the Postmenopausal OvaryJournal of Clinical Endocrinology & Metabolism, 1976